There is a new opportunity for young scientists to make their mark in the field of immuno-oncology. In an effort to encourage and support the development of innovative treatments, Bristol Myers Squibb-Stiftung Immunonkologie has published a call for not-habilitated researchers under the age of 40 who are currently affiliated with research institutions in Germany.